How were Nexeon Medsystems' earnings last quarter?

Nexeon Medsystems Inc (OTCMKTS:NXNN) announced its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The firm had revenue of $2.87 million for the quarter, compared to analyst estimates of $1.70 million.

What other stocks do shareholders of Nexeon Medsystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nexeon Medsystems investors own include Allena Pharmaceuticals (ALNA) , Ampliphi Biosciences (APHB) , Fate Therapeutics (FATE) , ObsEva (OBSV) , Vaxart (VXRT) , Arbutus Biopharma (ABUS) , Aurora Cannabis (ACBFF) , AC Immune (ACIU) , AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX) .

How do I buy shares of Nexeon Medsystems?

Shares of NXNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NXNN

Nexeon Medsystems (NXNN) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free NXNN Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart

Get Nexeon Medsystems alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Nexeon Medsystems Stock (OTCMKTS:NXNN)

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

NXNN Stock News Headlines

December 13, 2023 | morningstar.com

Nexeon MedSystems Inc NXNN

April 1, 2023 | benzinga.com

Relievant Medsystems Receives 2023 Gallup Exceptional Workplace Award

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 29, 2023 | benzinga.com

FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView™ Falloposcope

January 15, 2023 | bizjournals.com

Battery tech company Group14 files lawsuit against British competitor Nexeon

October 16, 2022 | finance.yahoo.com

Nexeon MedSystems Inc. (NXNN)

See More Headlines

Receive NXNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexeon Medsystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/21/2018
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:NXNN
CUSIP: N/A
CIK: N/A
Web: www.nexeonmed.com
Phone: (954) 837-6833
Fax: N/A
Employees: 62
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 6.98

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. William Rosellini J.D. (Age 44)
M.B.A., M.S., Chairman & CEO
Comp: $2
Mr. Christopher R. Miller (Age 54)
Chief Financial Officer
Comp: $131.75k
Mr. Cathal Mc Fadden
Vice President of Operations
Dr. Austin Duke Ph.D.
Chief Science Officer

Key Competitors

View All Competitors

NXNN Stock Analysis - Frequently Asked Questions

How were Nexeon Medsystems' earnings last quarter?: Nexeon Medsystems Inc (OTCMKTS:NXNN) announced its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The firm had revenue of $2.87 million for the quarter, compared to analyst estimates of $1.70 million.
What other stocks do shareholders of Nexeon Medsystems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nexeon Medsystems investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Fate Therapeutics (FATE), ObsEva (OBSV), Vaxart (VXRT), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AC Immune (ACIU), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).
How do I buy shares of Nexeon Medsystems?: Shares of NXNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NXNN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial